|
Volumn 25, Issue 3, 2013, Pages
|
Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CITALOPRAM;
MEDROXYPROGESTERONE ACETATE;
RISPERIDONE;
VENLAFAXINE;
ZUCLOPENTHIXOL;
ADULT;
AGGRESSION;
AGITATION;
BEHAVIOR DISORDER;
CASE REPORT;
CLINICAL FEATURE;
DRUG DOSE INCREASE;
DRUG TOLERABILITY;
FLUID RETENTION;
HUMAN;
HUNTINGTON CHOREA;
LETTER;
MALE;
MOTOR DYSFUNCTION;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
SCORING SYSTEM;
SOMNOLENCE;
TREATMENT RESPONSE;
AGGRESSION;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTIPSYCHOTIC AGENTS;
CLOPENTHIXOL;
HUMANS;
HUNTINGTON DISEASE;
INJECTIONS, INTRAMUSCULAR;
MALE;
MEDROXYPROGESTERONE ACETATE;
PSYCHOMOTOR AGITATION;
|
EID: 84883861603
PISSN: 08950172
EISSN: 15457222
Source Type: Journal
DOI: 10.1176/appi.neuropsych.12070164 Document Type: Letter |
Times cited : (3)
|
References (3)
|